BU and Johnson & Johnson Innovation Team Up to Fight Lung Cancer

June 6, 2018
In what Boston University President Robert A. Brown envisions as a model for industry and academia collaborating to improve human health, BU has launched a five-year translational research alliance with Johnson & Johnson Innovation LLC (JJI) aimed at preventing, intercepting, and curing lung cancer, the leading cause of cancer deaths worldwide. As part of the new alliance, Johnson & Johnson Innovation will fund a Johnson & Johnson Innovation Lung Cancer Center at Boston University on the Medical Campus, where BU researchers will work closely with members of the Lung Cancer Initiative within Johnson & Johnson to develop biomarker-based early-screening tests for lung cancer, as well as therapeutics to arrest or eradicate the disease in its earliest stages. The goal is to combine the resources of healthcare giant J&J with expertise at Boston University to speed the development of interventions and cures. Read the full article here.

Learn More

What is Public Relations?

Whether you’re looking to promote your research, a new initiative, an event, or are preparing for an interview with national media, BU Public Relations is here to help. We’ll work with you to focus your message, develop a communication strategy, and get the word out.

Learn About Our Services Get In Touch

{
Media Training

617-353-2240
pr@bu.edu

Op-Ed & Commentary Assistance

617-353-2240
pr@bu.edu

Faculty Experts

617-353-2240
pr@bu.edu

Content Sharing

617-353-2240
pr@bu.edu

Event Publicity

617-353-2240
pr@bu.edu

Broadcast Studio

617-353-2240
pr@bu.edu